ERBB2 and breast cancer: Importantly, the PI3K-AKT pathway is frequently dysregulated in HER2+ BC and affects gene transcription (CCND/CCNE), and deactivates regulatory proteins (p27Kip1/p21Cip1) of cell cycle machinery that facilitates uncontrolled cell proliferation and oncogenic transformation [28].